{"brief_title": "Comparative Effectiveness of a Breath-operated Albuterol Inhaler in Asthma Patients With Poor Inhaler Technique", "brief_summary": "This study was designed to examine the effectiveness of a breath-operated albuterol inhaler in asthma patients who have difficulty using their standard \"press-and-breathe\" inhaler.", "detailed_description": "This was a single-center, randomized, open-label, active-controlled, 2-period, 2-sequence, single dose-dose, crossover comparison of the ability of Albuterol BOI-HFA to produce bronchodilation relative to that produced by to albuterol MDI-HFA in at least 12 asthmatics with poor inhaler coordinating ability.", "condition": ["Asthma"], "intervention_type": ["Drug", "Drug"], "intervention_name": ["Albuterol HFA-BOI", "Albuterol HFA-MDI"], "description": ["Albuterol HFA breath operated inhaler, 90 mcg/sprau", "Albuterol HFA multi-dose inhaler"], "arm_group_label": ["Albuterol HFA-BOI", "Albuterol HFA-MDI"], "other_name": ["Proair HFA-MDI"], "criteria": "Inclusion Criteria: - Asthma diagnosed \u22656 months prior and stable for 4 weeks prior to screening - Poor inhaler coordination as assessed at screening - Reversible bronchoconstriction (\u2265 12% increase in FEV1) Exclusion Criteria: - Albuterol allergy - Investigational drug within 30 days - Injected corticosteroid within 6 weeks - Requires beta-blockers, MAO inhibitors, tricyclic antidepressants, long-acting beta-blockers, steroids other than those inhaled - Other criterial apply", "gender": "All", "minimum_age": "18 Years", "maximum_age": "N/A", "healthy_volunteers": "No", "mesh_term": ["Asthma", "Albuterol"], "id": "NCT00054964"}